sulforaphane has been researched along with Hemorrhage, Subarachnoid in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zolnourian, AH | 1 |
| Franklin, S | 1 |
| Galea, I | 1 |
| Bulters, DO | 1 |
| Zhao, X | 1 |
| Wen, L | 1 |
| Dong, M | 1 |
| Lu, X | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| SFX-01 After Subarachnoid Haemorrhage[NCT02614742] | Phase 2 | 90 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sulforaphane and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; alpha-Cyclodextrins; Cardiovascula | 2020 |
1 other study available for sulforaphane and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Sulforaphane activates the cerebral vascular Nrf2-ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage.
Topics: Animals; Appetite; Basilar Artery; Carboxylic Ester Hydrolases; Cytokines; Disease Models, Animal; D | 2016 |